DEINOVE (Alternext Paris: ALDEI), a biotech company that discovers, develops and produces high-value compounds from rare bacteria, notably from the Deinococcus genus, announces today its provisional financial calendar for 2017*.
- March 30, 2017: Publication of 2016 Annual Results
- May 16, 2017: Annual Shareholders Meeting, in Paris (11 :00 CET)
- September 28, 2017: Publication of 2017 First Half Financial Results
* This financial calendar is for indicative purposes only and the Company could change its publication dates should it deem necessary.